The regulator's review, which focused on topical antirheumatics and analgesics and expectorants, in particular in Latvia, Lithuania and Estonia, found that that the transaction would not threaten competition as it would not significantly change the market structure, the EC said.
The regulatora[euro](tm)s review, which focused on topical antirheumatics and analgesics and expectorants, in particular in Latvia, Lithuania and Estonia, found that that the transaction would not threaten competition as it would not significantly change the market structure, the EC said.